The shares sold for an average price of $170.18 per stock.
In addition, five other Cigna executives sold stocks within the past month, for a combined $1.9 million, roughly.
– Michael Triplett, president of U.S. markets, sold 1,439 shares of stock at the average price of $166.89 for about $240,154.
– William Zollars, director, sold 1,923 shares at the average price of $166.55 for about $320,275.
– Mary Hoeltzel, vice president and chief accounting officer, sold 500 shares at the average price of $166.70 for about $83,350.
– Jason Sadler, president of international markets, sold 1,727 shares at the average price of $164.59 for about $284,246.
– Matthew Manders, president of government and individual program and group policies, sold 6,000 shares at the average price of $165 for about $990,000.
More articles on payer issues:
4 things to know about BCBSA’s 2016 community health investments
Aetna moving HQs to attract ‘younger people, innovation’
Cigna CEO: 2017 growth could involve Medicare Advantage deals
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
